ULTA reports second-quarter results on August 27 with the stock riding a 13% one-month surge to $538.76 — yet options positioning has grown noticeably more defensive as the print approaches.
The shift in options sentiment is the clearest pre-earnings signal. The put/call ratio has climbed to 0.99, running about 1.65 standard deviations above its 20-day average of 0.88. That is not panic-level hedging — the 52-week high sits at 1.39 — but the directional trend is unambiguous. From late July through early August, the PCR held in the low-to-mid 0.80s. It has drifted steadily higher since, tracking almost exactly with the stock's 9% weekly rally. Investors are paying more for downside protection precisely as the price moves up into the print.
Short interest adds a degree of complexity. At 5.2% of free float, it is meaningful but not extreme. The short position actually declined about 2.8% over the past week — a modest cover — after edging up roughly 10.7% over the past month. Borrow conditions are loose: availability is near 2,086%, meaning there are roughly 20 shares available to lend for every one currently borrowed, and the cost to borrow is a negligible 0.46%. There is no squeeze pressure here. Short sellers are engaged but not cornered, and the lending market gives them ample room to add to positions post-print if the numbers disappoint.
The bull-bear debate centres on whether the recent momentum is built on solid fundamentals or optimism that has run ahead of the numbers. Bulls point to comparable sales growth of 5.8% — ahead of expectations and a sharp acceleration from a year earlier — alongside a projected 6–7% revenue growth trajectory for FY26 and improving e-commerce momentum. Bears note that gross margin has slipped to 38.1%, EPS of $8.01 missed consensus, and headwinds are building: the Target partnership winds down, competition from mass-market and direct-to-consumer beauty brands is intensifying, and the macro backdrop remains uncertain. Analysts trimmed targets broadly after the prior quarter — Goldman Sachs, JPMorgan, Morgan Stanley, and others all lowered price targets while maintaining positive ratings — leaving the consensus mean well above the current price. That gap implies the Street still sees fundamental value, but the target cuts also reflect reduced conviction. The analyst data predates the recent 13% rally, which has closed some of that gap.
The earnings history adds relevant context. The last ULTA print in early June produced a 5.9% one-day decline and a 4.6% loss over the following five days — a reminder that even well-owned retail names can gap down sharply on marginal misses. The stock has now recovered all of that ground and more heading into this quarter. The upcoming print is therefore as much a test of whether the recovery in comparable sales can be sustained at a margin profile that justifies the stock's re-rating as it is about the headline revenue number.
See the live data behind this article on ORTEX.
Open ULTA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
